Medi-Tech Insights Get in touch

Global Lung Cancer Diagnostics Market Size & Trends Report Segmented by Cancer Type (Non-small Cell Lung Cancer, Small Cell Lung Cancer), Test Type (CA, HER2, Others), End-user (Hospitals, Diagnostic Centers, Others) & Regional Forecasts to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  • Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  • Executive Summary
    • Lung Cancer Diagnostics Market Snapshot (2025-2030)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  • Increasing adoption of precision medicine for targeted therapies
  • Growing awareness of early detection and government screening initiatives
  • Improved healthcare access in emerging markets
  • Restraints
    • Complex regulatory landscape
    • High costs of advanced diagnostic tools
    • Variability in test accuracy and diagnostic outcomes across different platforms
  • Opportunities
    • Rising demand for non-invasive diagnostic methods like liquid biopsy
    • Development of AI-based tools enhancing imaging diagnostics (e.g., CT scans)
    • Increasing research collaborations to develop novel biomarker-based diagnostics
    • Growth in personalized medicine and companion diagnostics
  • Key Market Trends
    • Growing adoption of NGS for comprehensive lung cancer genomic profiling
    • Rising role of companion diagnostics in targeted therapies for biomarkers like EGFR, ALK, and HER2
    • Unmet Market Needs
    • Industry Speaks
  • Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Cancer Type, USD Million
    • Introduction
    • Non-small Cell Lung Cancer
    • Small Cell Lung Cancer
  • Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Test Type, USD Million
    • Introduction
    • CA Test
    • HER2 Test
    • ALK Test
    • Angiogenesis Inhibitors
    • EGFR Mutation Test
    • KRAS Mutation Test
  • Global Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By End-user, USD Million
    • Introduction
    • Hospitals
    • Diagnostic Centers
    • Others
  • Global Lung Cancer Diagnostics Market Size SD Million
    • Introduction
    • North America Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
      • US
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Canada
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
    • Europe Lung Cancer Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
      • UK
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Foron)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Italy
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Spain
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Rest of Europe
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Test Type (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
    • Asia Pacific (APAcer Type (USD Million)
    • Market Size & Forecast, By Test Type (USD Million)
    • Market Size & Forecast, By End-user (USD Million)
  • Japan
    • Market Size & Forecast, By Cancer Type (USD Million)
    • Market Size & Forecast, By Test Type (USD Million)
    • Market Size & Forecast, By End-user (USD Million)
  • India
    • Market Size & Forecast, By Cancer Type (USD Million)
    • Market Size & Forecast, By Test Type (USD Million)
    • Market Size & Forecast, By End-user (USD Million)
  • Rest of Asia Pacific
    • Market Size & Forecast, By Cancer Type (USD Million)
    • Market Size & Forecast, By Test Type (USD Million)
    • Market Size & Forecast, By End-user (USD Million)
  • Market Size & Forecast, By Test Type (USD Million)
  • Market Size & Forecast, By End-user (USD Million)
  • Middle East & Africa (MEA) Lung Cancer Diagnostics Market Size & Forecast (2023-2030), USD Million
    • Market Size & Forecast, By Cancer Type (USD Million)
    • Market Size & Forecast, By Test Type (USD Million)
    • Market Size & Forecast, By End-user (USD Million)
  • Competitive Landscape
  • Key Players and their Competitive Positioning
    • Key Player Comparison
    • Segment-wise Player Mapping
    • Market Share Analysis (2024)
    • Company Categorization Matrix
      • Dominants/Leaders
      • New Entrants
      • Emerging Players
      • Innovative Players
  • Key Strategies Assessment, By Player (2022-2024)
    • Neers & Acquisitions
    • Geographic Expansion
  • Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
      • Hoffmann-La Roche Ltd
      • Thermo Fisher Scientific
      • Agilent Technologies
      • Qiagen
      • Abbott
      • Bio-Rad Laboratories, Inc.
      • Neogenomics Laboratories
      • Myriad Genetics, Inc.
      • Illumina Inc.
      • Other Prominent Players

    Note: *Indicative list

    **For listed com

    Related Reports

    View All Research Reports